After Decades of Pressure, US Drugmaker J & J Gives Up Patent on Life-Saving TB Drug

New Delhi: In what can be termed a huge development for drug-resistant TB (DR-TB) patients across large parts of the world, bedaquiline maker Johnson and Johnson said on September 30 (Saturday) that it would drop its patent over the drug in 134 low- and middle-income countries (LMICs). Bedaquiline…#newdelhi #tb #dr #bedaquiline #sirturo #msf #pregrantopposition #ganeshacharya #mumbai #stoptbpartnership

Source: Reuters: Health - October 1, 2023 Category: Consumer Health News Source Type: news